Literature DB >> 17561809

Sp1 and Sp3 control constitutive expression of the human NHE2 promoter by interactions with the proximal promoter and the transcription initiation site.

Ian Pearse1, Ying X Zhu, Eleanor J Murray, Pradeep K Dudeja, Krishnamurthy Ramaswamy, Jaleh Malakooti.   

Abstract

We have previously cloned the human Na+/H+ exchanger NHE2 gene and its promoter region. In the present study, the regulatory elements responsible for the constitutive expression of NHE2 were studied. Transient transfection assays revealed that the -40/+150 promoter region contains the core promoter responsible for the optimal promoter activity. A smaller fragment, -10/+40, containing the TIS (transcription initiation site) showed minimal activity. We identified a palindrome that overlaps the TIS and binds to the transcription factors Sp1 and Sp3. Mutations in the 5' flank of the palindrome abolished the Sp1/Sp3 interaction and reduced promoter activity by approx. 45%. In addition, a conserved GC-box centered at -25 was found to play a critical role in basal promoter activity and also interacted with Sp1 and Sp3. An internal deletion in the GC-box severely reduced the promoter activity. Sp1/Sp3 binding to these elements was established using gel-mobility shift assays, confirmed by chromatin immunoprecipitation and co-transfections in Drosophila SL2 cells. Furthermore, we identified two positive regulatory elements in the DNA region corresponding to the 5'-UTR (5'-untranslated region). The results in the present study indicate that Sp1 and Sp3 are required for constitutive NHE2 expression and that the positive regulatory elements of the 5'-UTR may co-operate with the 5'-flanking region to achieve the optimal promoter activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561809      PMCID: PMC2267401          DOI: 10.1042/BJ20070364

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

Review 1.  The expanding family of eucaryotic Na(+)/H(+) exchangers.

Authors:  L Counillon; J Pouysségur
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

Review 2.  Regulation of the activity of Sp1-related transcription factors.

Authors:  Peter Bouwman; Sjaak Philipsen
Journal:  Mol Cell Endocrinol       Date:  2002-09-30       Impact factor: 4.102

3.  Epidermal growth factor regulation of rat NHE2 gene expression.

Authors:  H Xu; J F Collins; L Bai; P R Kiela; R M Lynch; F K Ghishan
Journal:  Am J Physiol Cell Physiol       Date:  2001-08       Impact factor: 4.249

4.  Molecular cloning and functional analysis of the human Na(+)/H(+) exchanger NHE3 promoter.

Authors:  Jaleh Malakooti; V C Memark; Pradeep K Dudeja; Krishnamurthy Ramaswamy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-03       Impact factor: 4.052

5.  CpG islands in vertebrate genomes.

Authors:  M Gardiner-Garden; M Frommer
Journal:  J Mol Biol       Date:  1987-07-20       Impact factor: 5.469

6.  Intestinal NaCl transport in NHE2 and NHE3 knockout mice.

Authors:  Lara R Gawenis; Xavier Stien; Gary E Shull; Patrick J Schultheis; Alison L Woo; Nancy M Walker; Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-05       Impact factor: 4.052

7.  Lysophosphatidic acid stimulates brush border Na+/H+ exchanger 3 (NHE3) activity by increasing its exocytosis by an NHE3 kinase A regulatory protein-dependent mechanism.

Authors:  Whaseon Lee-Kwon; Kazuya Kawano; Jung Woong Choi; Jae Ho Kim; Mark Donowitz
Journal:  J Biol Chem       Date:  2003-02-20       Impact factor: 5.157

8.  Transcriptional regulation of rat Na(+)/H(+) exchanger isoform-2 (NHE-2) gene by Sp1 transcription factor.

Authors:  L Bai; J F Collins; H Xu; F K Ghishan
Journal:  Am J Physiol Cell Physiol       Date:  2001-05       Impact factor: 4.249

9.  Low pH enhances Sp1 DNA binding activity and interaction with TBP.

Authors:  Takayuki Torigoe; Hiroto Izumi; Yoichiro Yoshida; Hiroshi Ishiguchi; Takashi Okamoto; Hideaki Itoh; Kimitoshi Kohno
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

10.  Metabolic acidosis in rats increases intestinal NHE2 and NHE3 expression and function.

Authors:  Alvaro Lucioni; Christopher Womack; Mark W Musch; Flavio L Rocha; Cres Bookstein; Eugene B Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-07       Impact factor: 4.052

View more
  5 in total

1.  Tumor necrosis factor-α represses the expression of NHE2 through NF-κB activation in intestinal epithelial cell model, C2BBe1.

Authors:  Md Ruhul Amin; Temitope Orenuga; Sangeeta Tyagi; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

Review 2.  Transcriptional regulation of the intestinal luminal Na⁺ and Cl⁻ transporters.

Authors:  Jaleh Malakooti; Seema Saksena; Ravinder K Gill; Pradeep K Dudeja
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

3.  PKCδ-dependent activation of ERK1/2 leads to upregulation of the human NHE2 transcriptional activity in intestinal epithelial cell line C2BBe1.

Authors:  Saminathan Muthusamy; Sagar Shukla; Md Ruhul Amin; Ming Cheng; Temitope Orenuga; Pradeep K Dudeja; Jaleh Malakooti
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-03       Impact factor: 4.052

Review 4.  The Role of Plasma Membrane Sodium/Hydrogen Exchangers in Gastrointestinal Functions: Proliferation and Differentiation, Fluid/Electrolyte Transport and Barrier Integrity.

Authors:  Katerina Nikolovska; Ursula E Seidler; Christian Stock
Journal:  Front Physiol       Date:  2022-05-18       Impact factor: 4.755

5.  Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.

Authors:  Manonmani Ganapathy; Rita Ghosh; Xie Jianping; Xiaoping Zhang; Roble Bedolla; John Schoolfield; I-Tien Yeh; Dean A Troyer; Aria F Olumi; Addanki P Kumar
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.